Antibody may be detectable in blood years before multiple sclerosis symptoms appear

February 21, 2014, American Academy of Neurology

An antibody found in the blood of people with multiple sclerosis (MS) may be present long before the onset of the disease and its symptoms, according to a study released today that will be presented at the American Academy of Neurology's 66th Annual Meeting in Philadelphia, April 26 to May 3, 2014.

"If our results can be replicated in larger populations, our findings may help to detect MS earlier in a subgroup of patients," said study author Viola Biberacher, MD, with Technical University in Munich, Germany. "Finding the disease before appear means we can better prepare to treat and possibly even prevent those symptoms. This finding also demonstrates that the antibody development to the KIR4.1 protein, a protein found in some people with MS, precedes the clinical onset of disease suggesting a role of the autoantibody in how the disease develops."

For the study, 16 healthy who were later diagnosed with MS were compared to 16 healthy blood donors of the same age and sex who did not develop MS. Scientists looked for a specific antibody to KIR4.1. Samples were collected between two and nine months before the first symptoms of MS appeared.

Next, researchers looked at in the blood at additional time points up to six years before and then after disease onset in those who had the KIR4.1 antibody in their .

All of the healthy controls tested negative for the KIR4.1 antibody. Of those who later developed MS, seven people tested positive for the antibodies, two showed borderline activity and seven were negative.

In the study, KIR4.1 were found in the people with pre-clinical MS several years before the first clinical attack. Concentrations of the antibody varied at different time points during pre-MS in individual people.

"The next step is to confirm these findings in larger groups and determine how many years before onset of disease the antibody response develops," said Biberacher.

Explore further: Novel immune target identified in multiple sclerosis

Related Stories

Novel immune target identified in multiple sclerosis

July 12, 2012
(HealthDay) -- About half of a subgroup of patients with multiple sclerosis have autoantibodies to a potassium channel in the brain, according to a study published in the July 12 issue of the New England Journal of Medicine.

Boosting vitamin D could slow progression, reduce severity of multiple sclerosis

January 20, 2014
For patients in the early stages of multiple sclerosis (MS), low levels of vitamin D were found to strongly predict disease severity and hasten its progression, according to a new study led by Harvard School of Public Health ...

Bacterial toxin a potential trigger for multiple sclerosis

January 28, 2014
Researchers from Weill Cornell Medical College have added to the growing body of evidence that multiple sclerosis may be triggered by a toxin produced by common foodborne bacteria. The presented their research at the 2014 ...

Modest familial risks for multiple sclerosis

January 22, 2014
Even though multiple sclerosis is largely caused by genetic factors, the risk of patients relatives developing the disease is lower than previously assumed. This is the conclusion of a new population registry-based study, ...

Research reveals new understanding, warning signs, and potential treatments for multiple sclerosis

November 10, 2013
Scientists are gaining a new level of understanding of multiple sclerosis (MS) that may lead to new treatments and approaches to controlling the chronic disease, according to new research released today at Neuroscience 2013, ...

Recommended for you

Recording a thought's fleeting trip through the brain

January 17, 2018
University of California, Berkeley neuroscientists have tracked the progress of a thought through the brain, showing clearly how the prefrontal cortex at the front of the brain coordinates activity to help us act in response ...

Midbrain 'start neurons' control whether we walk or run

January 17, 2018
Locomotion comprises the most fundamental movements we perform. It is a complex sequence from initiating the first step, to stopping when we reach our goal. At the same time, locomotion is executed at different speeds to ...

Brain zaps may help curb tics of Tourette syndrome

January 16, 2018
Electric zaps can help rewire the brains of Tourette syndrome patients, effectively reducing their uncontrollable vocal and motor tics, a new study shows.

A 'touching sight': How babies' brains process touch builds foundations for learning

January 16, 2018
Touch is the first of the five senses to develop, yet scientists know far less about the baby's brain response to touch than to, say, the sight of mom's face, or the sound of her voice.

Researchers identify protein involved in cocaine addiction

January 16, 2018
Mount Sinai researchers have identified a protein produced by the immune system—granulocyte-colony stimulating factor (G-CSF)—that could be responsible for the development of cocaine addiction.

Neuroscientists suggest a model for how we gain volitional control of what we hold in our minds

January 16, 2018
Working memory is a sort of "mental sketchpad" that allows you to accomplish everyday tasks such as calling in your hungry family's takeout order and finding the bathroom you were just told "will be the third door on the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.